← Back to Discover
Monashee Investment Management LLC
Period ended Sep 30, 2026 · Latest filing Nov 6, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $33,404,308
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- AXON ENTERPRISE INC · NOTE 9/1 · 05464CAE1 · shares: $4,943,550
- IMMIX BIOPHARMA INC · COM · 45258H106 · shares: $4,682,250
- SYSCO CORP · COM · 871829107 · shares: $4,287,800
- NEWCLEO PLC · ORDINARY SHARES · G6448L103 · shares: $3,140,000
- ADT INC DEL · COM · 00090Q103 · shares: $3,040,000
- SOLID BIOSCIENCES INC · COM NEW · 83422E204 · shares: $2,964,300
- ENBRIDGE INC · COM · 29250N105 · shares: $2,324,500
- VIKING THERAPEUTICS INC · NOTE 2.000%10/1 · 92686JAA4 · shares: $1,537,725
- BLOSSOMHILL THERAPEUTICS INC · COM · 095130100 · shares: $1,491,200
- ELECTRA THERAPEUTICS INC · COM · 284825106 · shares: $1,125,000
Reported holdings
16 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| AXON ENTERPRISE INC | NOTE 9/1 | 05464CAE1 | — | 5,000,000 shares | $4,943,550 |
| IMMIX BIOPHARMA INC | COM | 45258H106 | — | 450,000 shares | $4,682,250 |
| SYSCO CORP | COM | 871829107 | — | 55,000 shares | $4,287,800 |
| NEWCLEO PLC | ORDINARY SHARES | G6448L103 | — | 400,000 shares | $3,140,000 |
| ADT INC DEL | COM | 00090Q103 | — | 500,000 shares | $3,040,000 |
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | — | 410,000 shares | $2,964,300 |
| ENBRIDGE INC | COM | 29250N105 | — | 50,000 shares | $2,324,500 |
| VIKING THERAPEUTICS INC | NOTE 2.000%10/1 | 92686JAA4 | — | 1,500,000 shares | $1,537,725 |
| BLOSSOMHILL THERAPEUTICS INC | COM | 095130100 | — | 80,000 shares | $1,491,200 |
| ELECTRA THERAPEUTICS INC | COM | 284825106 | — | 100,000 shares | $1,125,000 |
| YARROW BIOSCIENCE INC | COM | 92941V407 | — | 40,000 shares | $900,800 |
| IMAGENEBIO INC | COM | 45175G207 | — | 177,094 shares | $811,091 |
| AVEANNA HEALTHCARE HLDGS INC | COM | 05356F105 | — | 50,000 shares | $620,500 |
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | — | 229,310 shares | $534,292 |
| ORION180 INS GROUP INC | COM CL A | 68629T104 | — | 55,000 shares | $530,200 |
| HAGERTY INC | CL A COM | 405166109 | — | 35,000 shares | $471,100 |